Misaki Ono
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Retinoids in leukemia and cellular processes 5
- Metabolism, Diabetes, and Cancer 2
- Plant biochemistry and biosynthesis 2
-
- Phytoestrogen effects and research 5
- Co-authors
- Mikako Takeshima (13 shared papers)Shuji Nakano (15 shared papers)Yuko Kai (2 shared papers)Osamu Ezaki (2 shared papers)Shinji Miura (2 shared papers)Takayuki Hara (1 shared paper)S Nakano (3 shared papers)陈晨 (1 shared paper)
- Journals
- Nutrition and Cancer (3 papers)Cancer Research (2 papers)Journal of Clinical Hypertension (2 papers)Biochemical and Biophysical Research Communications (2 papers)ESMO Open (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Misaki Ono
21 papers receiving 483 citations
Peers
Comparison fields: 5 of 84
- Biochemistry 112
- Molecular Medicine 48
- Applied Microbiology and Biotechnology 10
- Geriatrics and Gerontology 19
- Physiology 123
Countries citing papers authored by Misaki Ono
This map shows the geographic impact of Misaki Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misaki Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misaki Ono more than expected).
Fields of papers citing papers by Misaki Ono
This network shows the impact of papers produced by Misaki Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misaki Ono. The network helps show where Misaki Ono may publish in the future.
Co-authors
The 25 scholars most cited alongside Misaki Ono, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 130 | |
| 2 | 2014 | 105 | |
| 3 | 2015 | 50 | |
| 4 | 2017 | 38 | |
| 5 | Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. | 2014 | 38 |
| 6 | Antiproliferative and apoptosis-inducing activity of curcumin against human gallbladder adenocarcinoma cells. | 2013 | 27 |
| 7 | 2017 | 25 | |
| 8 | 2013 | 16 | |
| 9 | 2020 | 16 | |
| 10 | 2003 | 9 | |
| 11 | 2017 | 7 | |
| 12 | 2017 | 7 | |
| 13 | 2012 | 5 | |
| 14 | 2013 | 4 | |
| 15 | 2009 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2013 | 1 | |
| 20 | 2018 | 1 |
About Misaki Ono
Misaki Ono is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Public Health, Environmental and Occupational Health and Molecular Medicine, having authored 22 papers that have together received 490 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (5 papers), Phytoestrogen effects and research (5 papers), Nutritional Studies and Diet (3 papers), Curcumin's Biomedical Applications (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Adipose Tissue and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers) and Plant biochemistry and biosynthesis (2 papers). The work is most often cited by research in Biochemistry (112 citations), Molecular Medicine (48 citations), Applied Microbiology and Biotechnology (10 citations), Geriatrics and Gerontology (19 citations) and Physiology (123 citations). Misaki Ono has collaborated with scholars based in Japan and United States. Frequent co-authors include Mikako Takeshima, Shuji Nakano, Yuko Kai, Osamu Ezaki, Shinji Miura, Takayuki Hara, S Nakano, 陈晨, Chen Chen and Nobuyo Tsunoda. Their work appears in journals such as Nutrition and Cancer, Cancer Research, Journal of Clinical Hypertension, Biochemical and Biophysical Research Communications and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.